Rudy Birsen Selected Research

Rudy Birsen Research Topics

Disease

9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 09/2015
4	Lymphoma (Lymphomas) 08/2023 - 01/2018
4	Neoplasms (Cancer) 01/2023 - 09/2015
3	Leukemia 04/2024 - 01/2020
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2024 - 01/2022
2	Hemolysis 01/2023 - 10/2022
2	Hematologic Neoplasms (Hematological Malignancy) 10/2022 - 09/2022
1	Rheumatoid Arthritis 01/2024
1	Hodgkin Disease (Hodgkin's Disease) 08/2023
1	Hyperkalemia 08/2023
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2023
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2023
1	Thrombosis (Thrombus) 01/2023
1	COVID-19 10/2022
1	Glucosephosphate Dehydrogenase Deficiency 10/2022
1	Multiple Myeloma 09/2022
1	Oncogene Addiction 01/2022
1	Primary Effusion Lymphoma 01/2017
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2016
1	Hemorrhagic Cystitis 09/2016

Drug/Important Bio-Agent (IBA)

1	Biomarkers (Surrogate Marker)IBA 04/2024
1	Lenalidomide (CC 5013)FDA Link 01/2024
1	Azacitidine (5 Azacytidine)FDA Link 10/2023
1	Chimeric Antigen ReceptorsIBA 08/2023
1	Hemoglobins (Hemoglobin)IBA 08/2023
1	Immune Checkpoint InhibitorsIBA 08/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	fms-Like Tyrosine Kinase 3IBA 01/2023
1	eculizumab FDA Link 01/2023
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Complement Factor H (Factor H)IBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	LipidsIBA 01/2023
1	Monoclonal AntibodiesIBA 10/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2022
1	rasburicase (Elitek)FDA Link 10/2022
1	Bortezomib (Velcade)FDA Link 09/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2022
1	eprenetapoptIBA 01/2022
1	trametinibIBA 01/2022
1	GSK621IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	AMP-Activated Protein KinasesIBA 11/2021
1	venetoclaxIBA 11/2021
1	1- ((2- ((2- chloropyridin- 4yl)amino)- 4'- (cyclopropylmethyl)- (4,5'- bipyrimidin)- 2'- yl)amino)- 2- methylpropan- 2- olIBA 10/2020
1	IronIBA 01/2020
1	alpha-hydroxyglutarateIBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Talc FDA Link 01/2017
1	ibrutinibIBA 12/2016
1	Glutamine (L-Glutamine)FDA Link 09/2015

Therapy/Procedure

2	Immunotherapy 08/2023 - 10/2022
2	Therapeutics 09/2022 - 01/2022
1	Neurosurgical Procedures 09/2022
1	Length of Stay 09/2022
1	Pleurodesis 01/2017
1	Hematopoietic Stem Cell Transplantation 09/2016